ArticleRSC advances2023
Preparation and characterization of doped hollow carbon spherical nanostructures with nickel and cobalt metals and their catalysis for the green synthesis of pyridopyrimidines.
Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Efficient synthesis of tetrazolesRSC advances · 2025Article
- Nickel ferrite nanoparticles doped on hollow carbon microspheres as a novel reusable catalyst for synthesis of N-substituted pyrrole derivatives.Scientific reports · 2023Article
- Fabrication and characterization of mesoporous yolk-shell nanocomposites as an effective reusable heterogeneous base catalyst for the synthesis ofRSC advances · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fused heterocyclic systems containing the pyrimidine ring structure perform a significant role in numerous biological and pharmaceutical processes. Their properties include antibacterial, antifungal, anti-fever, anti-tumor, and antihistamine. As pyridopyrimidines are important in the essential fields of pharmaceutical chemistry, efficient methods for preparing these heterocycles are presented. In this study, a method for producing improved hollow carbon sphere nanostructures with cobalt and nickel (Co-Ni@HCSs) is presented. The nanocatalyst was prepared and identified by applying Fourier-transform infrared spectroscopy (FT-IR), X-ray powder diffraction (XRD), field-emission scanning electron microscopy (FE-SEM), transmission electron microscopy (TEM), energy-dispersive X-ray spectroscopy (EDS), Brunauer-Emmett-Teller (BET), and elemental mapping techniques. The Co-Ni@HCSs nanocatalyst was proved to be highly efficient in synthesizing pyranopyrimidine derivatives. The sizeable active site, economic catalyst loading, easy workup, reusability, green reaction conditions, and excellent yields of all derivatives are some of the significant features of this process. Also, applying response surface methodology (RSM) and the Box-Behnken design (BBD) techniques allowed us to determine the influential factors of the laboratory variables and identify the optimum conditions for superior catalytic activity. Finally, synthesized organic compounds were identified by utilizing melting point, FT-IR, and hydrogen-1 nuclear magnetic resonance (
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.